CALGARY, June 2, 2017 /CNW/ - TheraCann International Benchmark Corporation, a leading full serviceinternational cannabis consultancy ("TheraCann" or "the Company"), has announced today that as of May 29th, 2017 the Company terminated the consulting agreement with Maple Leaf Green World Inc. (TSXV: MGW) due
TheraCann's terminated agreement included a full review of Maple Leaf's Access to Cannabis for Medical Purposes (ACMPR) Application, site suitability audits, cultivation strategies, and project security overview. The company has stated that Maple Leaf Green World Inc. has not operated in good faith and has failed to fulfill their obligations as pursuant to the agreement including but not limited to; utilizing TheraCann's reputation to raise capital without fulfilling any commitment to, or intention of, employing TheraCann's services, misleading Company representatives as to material facts relating to their ACMPR application, and failure to remunerate TheraCann for agreed services rendered.
TheraCann will be pursuing any and all remedies to negotiate this material contract breach by Maple Leaf Green World and will continue until the Company deems a suitable resolution is achieved.
About TheraCann International Benchmark Corporation
TheraCann International Benchmark Corporation offers a one-stop, full-service solution for the International cannabis marketplace. From regulatory applications, planning, facility design, cultivation, marketing and communications, TheraCann provides cannabis-related businesses with solutions to fit their regulatory requirements. More information about TheraCann is available at www.theracanncorp.com.
SOURCE TheraCann International
Subscribe to our Free Newsletters!
Erythropoietin is a hormone secreted by kidneys in response to low oxygen levels in tissues ...
Local anesthesia is a type of anesthesia generally used to block pain sensation only in a specific ...
Sea food allergy is the adverse response of the body''s immune system to the proteins present in ...View All